Transgenic overexpression of HSP56 does not result in cardiac hypertrophy nor protect from ischaemia/reperfusion injury
Christopher J. Carroll(St George's, University of London), Paul A. Townsend(University College London), David J. Faulkes(University College London), Richard A. Knight(Institute of Child Health), David S. Latchman(Laboratory of Molecular Genetics), Anastasis Stephanou(Laboratory of Molecular Genetics), James K.J. Diss(University College London), Naushaad Suleman(University of Cape Town), Sean M. Davidson(University College London)
Cited by 2
Related Papers
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386
A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release
|Endocrinology|2008|382
Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury
|Journal of Molecular and Cellular Cardiology|2006|312